Drugs in Dev.
Genetic Disease
Discovery Platform
Denmark 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Discovery Platform
Sponsor : Casma Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement
Details : Under the terms of the agreement, Vipergen will apply its proprietary high-fidelity DNA-encoded library (DEL) technology platform to discover novel small-molecule drug leads against a broad range of undisclosed Casma discovery targets.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
December 01, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Discovery Platform
Sponsor : Casma Therapeutics
Deal Size : Undisclosed
Deal Type : Agreement
